Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-003099
Filing Date
2019-02-08
Accepted
2019-02-08 21:00:17
Documents
1
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 12388
  Complete submission text file 0000899243-19-003099.txt   13753
Mailing Address C/O DICERNA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
FAMBROUGH DOUGLAS (Reporting) CIK: 0001259856 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36281 | Film No.: 19581584

Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations